What does the presence of mecA (methicillin-resistant gene A) or mecC (methicillin-resistant gene C) indicate in a bacterial isolate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding mecA and mecC Genes in Bacterial Isolates

The presence of mecA or mecC genes in a bacterial isolate definitively indicates methicillin resistance, most commonly in Staphylococcus aureus, conferring resistance to all commercially available β-lactam antibiotics and requiring alternative antimicrobial treatment strategies. 1

Molecular Basis of Methicillin Resistance

mecA Gene

  • Encodes a modified penicillin-binding protein (PBP2a) with reduced affinity for β-lactam antibiotics 1
  • Carried on mobile genetic elements called Staphylococcal Cassette Chromosome mec (SCCmec) 1
  • SCCmec elements contain two essential components:
    • mec gene complex (contains mecA)
    • ccr gene complex (contains site-specific recombinase genes) 1
  • Strains carrying mecA are resistant to all commercially available β-lactams 1

mecC Gene

  • A homolog of mecA (shares 63% similarity) 2
  • More recently discovered variant that also confers methicillin resistance
  • Also carried on SCCmec elements (typically SCCmecXI) 3
  • Encodes a transpeptidase enzyme functionally similar to PBP2a 2

Clinical Significance

Diagnostic Implications

  • Molecular detection of mecA/mecC is the most accurate method for identifying methicillin resistance 1
  • Rapid molecular identification of these genes allows for:
    • Earlier initiation of appropriate antimicrobial therapy 1
    • Reduced mortality in serious infections 1
    • Better antimicrobial stewardship 1

Treatment Implications

  • Isolates positive for mecA or mecC require non-β-lactam antibiotics 1
  • Recommended treatment options include:
    • Vancomycin (first-line for MRSA infections) 1
    • Linezolid 1
    • Daptomycin 1
    • Teicoplanin 2
    • Trimethoprim-sulfamethoxazole (for less severe infections) 1
    • Tetracyclines (doxycycline or minocycline) 1

Epidemiological Considerations

mecA vs. mecC Distribution

  • mecA is far more prevalent globally than mecC 4
  • In a multi-center study in Pakistan (2023), among MRSA isolates:
    • 31.8% carried mecA alone
    • 7.9% carried mecC alone
    • 57.1% carried both mecA and mecC 2
  • mecC has been detected in several European countries but may be absent in certain regions 4, 3

Clinical Presentation

  • Both mecA and mecC positive isolates can cause severe infections, including fatal bacteremia 3
  • No significant difference in virulence has been established between mecA and mecC positive strains

Testing Considerations

  • Molecular methods (PCR) are superior to phenotypic testing for detecting mecA/mecC 5
  • Rapid diagnostic tests that detect these genes improve time to appropriate therapy 1
  • Some discrepancies between genotypic and phenotypic resistance determination can occur, though rare 1
  • Nucleic acid lateral flow immunoassays (NALFIA) offer rapid, reliable detection of both mecA and mecC genes 6

Important Caveats

  • Detection of mecA/mecC alone doesn't identify the bacterial species - additional testing is needed to confirm the organism is S. aureus or another staphylococcal species 6
  • Some methicillin-resistant isolates may lack both mecA and mecC, suggesting alternative resistance mechanisms 4
  • Heterogeneous expression of methicillin resistance can complicate phenotypic susceptibility testing 5
  • Always correlate molecular findings with clinical presentation and conventional culture results for optimal patient management

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.